BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17276944)

  • 21. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting.
    Tan KB; Moncrieff M; Thompson JF; McCarthy SW; Shaw HM; Quinn MJ; Li LX; Crotty KA; Stretch JR; Scolyer RA
    Am J Surg Pathol; 2007 Dec; 31(12):1902-12. PubMed ID: 18043047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
    J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do melanoma patients from Southern climates have a worse outcome than those from Northern climates?
    Woodall CE; Martin RC; Stromberg AJ; Ginter B; Burton A; Ross MI; Edwards MJ; McMasters KM; Scoggins CR
    Am Surg; 2009 Aug; 75(8):687-92; discussion 692. PubMed ID: 19725291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of growth rates of local recurrences and in-transit metastases on survival of patients with cutaneous melanoma].
    Mikhnin AE; Barchuk AS; Wagner RI; Anisimov VV
    Vopr Onkol; 2004; 50(5):557-61. PubMed ID: 15715096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome?
    Carpenter S; Pockaj B; Dueck A; Gray R; Kurtz D; Sekulic A; Casey W
    Am J Surg; 2008 Dec; 196(6):834-42; discussion 842-3. PubMed ID: 19095097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor cell proliferation and motility estimates are prognostic factors in malignant melanoma.
    Smolle J; Hofmann-Wellenhof R; Kofler R; Soyer HP; Kerl H
    Anal Cell Pathol; 1993 Mar; 5(2):113-24. PubMed ID: 8466849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
    van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
    Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial neural networks estimating survival probability after treatment of choroidal melanoma.
    Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF
    Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic importance of tumor mitotic rate for patients with primary cutaneous melanoma.
    Busam KJ
    Ann Surg Oncol; 2004 Apr; 11(4):360-1. PubMed ID: 15070594
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
    Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
    Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
    Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
    Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plantar melanoma: is the prognosis always bad?
    Baumert J; Schmidt M; Kunte C; Volkenandt M; Ruzicka T; Berking C; Schmid-Wendtner MH
    Dermatol Surg; 2010 Aug; 36(8):1325-7. PubMed ID: 20584045
    [No Abstract]   [Full Text] [Related]  

  • 37. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S; Kamo R; Harada T; Ishii M
    Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil.
    Borges SZ; Bakos L; Cartell A; Wagner M; Agostini A; Lersch E
    Int J Dermatol; 2007 Jul; 46(7):679-86. PubMed ID: 17614794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
    Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G
    J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.